What is The Beauty Health Company's market cap?

The Beauty Health Company (SKIN) has a market capitalization of $96.9M and trades on NASDAQ.

What is The Beauty Health Company's revenue and profitability?

The Beauty Health Company generated $296.1M in trailing twelve-month revenue with a net loss of $6.1M, representing a net margin of -2.0%. Gross margin stands at 64.9%, with free cash flow of $28.5M. These figures are based on the Q1 2026 filing.

Who are The Beauty Health Company's competitors?

The Beauty Health Company's key competitors include Allergan Aesthetics, Solesence, Inc. Common Stock, The Estee Lauder Companies Inc. Class A, and others. These companies compete in similar markets and product categories.

What subsidiaries does The Beauty Health Company have?

The Beauty Health Company's subsidiaries include Hydrafacial, Edge Systems Intermediate, LLC, Esthetic Medical Inc..

Where is The Beauty Health Company headquartered?

The Beauty Health Company is headquartered in United States of America and employs approximately 881 people. It has been publicly traded since 2021.

The Beauty Health Company

SKIN

The Beauty Health Company is a global medical aesthetics firm that provides an integrated ecosystem of clinically proven skin health solutions.

Market cap

$96.94M-51.9%

Revenue$296.1M-8.2%

Net income-$6.1M+84.3%

Free cash flow$28.5M+42.7%

EPS (diluted)-$0.16+57.9%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 7, 2026

Revenue$64.9MMiss by $1.4M EPS-$0.05Beat by $0.04

Read the full report

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$74.5M

EPS estimate-$0.04

Financials

Q1 2026

Income statement

See full

Revenue$64.9M-6.7%

Gross profit$44.4M-8.5%

Operating income-$1.8M+85.0%

Net income-$6.6M+34.3%

EPS (diluted)-$0.05+37.5%

Balance sheet

See full

Cash & equivalents$204.4M-45.2%

Total debt$125.9M+756%

Total equity$55.2M+19.9%

Total assets$473.2M-29.8%

Cash flow

See full

Operating cash flow-$5.6M-285%

CapEx$224.0K+398%

Free cash flow-$5.8M-296%

Valuation & ratios

Valuation

See full

Market cap$96.94M-51.9%

Enterprise value$18.44M-95.2%

P/S0.3×-0.4×

Profitability

See full

Gross margin64.9%+8.3pp

Operating margin-3.6%-1.6pp

Net margin-2%-0.9pp

FCF margin9.6%—

Returns & leverage

See full

Return on equity-12%-5.4pp

Debt / equity2.3×+2.0×

Current ratio1.8×-5.7×

Segments

By geography

See full

Americas$44.6M-3.6%

Europe, the Middle East and Africa$13.7M-8.4%

Asia-Pacific$6.6M-21.2%

By product

See full

Consumables$46.4M-6.1%

Delivery Systems$18.5M-8.3%

Competitors

By market cap

AbbVie$453.91B+36.3%

Estee Lauder Companies Inc.$30.1B-9.6%

NuSkin Enterprises$249.5M-43.2%

The Beauty Health Company$96.9M-56.3%

Lifevantage Corporation$80.4M-51.4%

Solesence, Inc. Common Stock$65.7M-78.1%

Sonoma Pharmaceuticals, Inc.$5.5M+2.1%

Dermata Therapeutics, Inc.$5.2M+15.7%

By revenue growth

AbbVie+9.5%

Solesence, Inc. Common Stock+5.8%

Estee Lauder Companies Inc.+0.3%

The Beauty Health Company-8.2%

Lifevantage Corporation-12.2%

NuSkin Enterprises-14.2%

By net margin

AbbVie5.79%-1.5pp

NuSkin Enterprises3.78%+6.1pp

Lifevantage Corporation2.94%-1.2pp

Solesence, Inc. Common Stock1.56%-7.0pp

Estee Lauder Companies Inc.-1.67%0.0pp

The Beauty Health Company-2.04%+9.9pp

Profile

The Beauty Health Company is a global medical aesthetics firm that provides an integrated ecosystem of clinically proven skin health solutions. The company's value proposition centers on a 'razor/razor blade' model, combining advanced delivery systems with proprietary consumables to support the success of professional providers. Its flagship brand, Hydrafacial, serves as a leading professional skincare treatment that bridges the gap between consumer retail and medical aesthetics.

Competitive position

A leading player in the non-invasive hydradermabrasion market with a significant installed base and high brand awareness among esthetics consumers.

GeographiesUnited States, Canada, EMEA, APAC, Latin America

Customer segmentsMedical Professionals, Hospitality, Retail Spas

Business modelRazor/Razor Blade, Direct-to-Professional, B2B2C, Recurring Revenue

SuppliersContract manufacturers (North America, Europe, Asia), Component and raw material suppliers, Tooling and equipment providers, Serum co-development partners

CustomersMedical Spas, Dermatology Clinics, Plastic Surgery Practices, Luxury Hotels and Resorts, Beauty Retailers

CountryUnited States of America

Listed2021

Employees881.0

CEOPedro Malha

SectorConsumer Defensive

IndustryHousehold & Personal Products

Websitebeautyhealth.com

FilingsSEC EDGAR

Ask your AI about The Beauty Health Company.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is The Beauty Health Company's market cap?: The Beauty Health Company (SKIN) has a market capitalization of $96.9M and trades on NASDAQ.
What is The Beauty Health Company's revenue and profitability?: The Beauty Health Company generated $296.1M in trailing twelve-month revenue with a net loss of $6.1M, representing a net margin of -2.0%. Gross margin stands at 64.9%, with free cash flow of $28.5M. These figures are based on the Q1 2026 filing.
Who are The Beauty Health Company's competitors?: The Beauty Health Company's key competitors include Allergan Aesthetics, Solesence, Inc. Common Stock, The Estee Lauder Companies Inc. Class A, and others. These companies compete in similar markets and product categories.
What subsidiaries does The Beauty Health Company have?: The Beauty Health Company's subsidiaries include Hydrafacial, Edge Systems Intermediate, LLC, Esthetic Medical Inc..
Where is The Beauty Health Company headquartered?: The Beauty Health Company is headquartered in United States of America and employs approximately 881 people. It has been publicly traded since 2021.